Fagron NV (ARSUF)

USD 20.03

(0.0%)

Market Cap (In USD)

1.46 Billion

Revenue (In USD)

762.99 Million

Net Income (In USD)

70.54 Million

Avg. Volume

103.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
18.055-20.85
PE
-
EPS
-
Beta Value
0.257
ISIN
BE0003874915
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Rafael Padilla
Employee Count
-
Website
https://www.fagron.com
Ipo Date
2017-02-21
Details
Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.